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Abstract
Amphetamine-type substances are the second most widely used illicit drugs in the United States.
There is evidence to suggest that stimulant use (cocaine and methamphetamine) has a heritable
component, yet the areas of the genome underlying these use disorders are yet to be identified.
This study’s aims were to map loci linked to stimulant dependence, heavy use, and craving in an
American Indian community at high risk for substance dependence. DSM diagnosis of stimulant
dependence, as well as indices of stimulant “craving” and “heavy use”, were obtained using the
Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA). Genotypes were
determined for a panel of 791 micro-satellite polymorphisms in 381 members of multiplex
families using SOLAR. Stimulant dependence, stimulant “craving” and “heavy stimulant use”,
were all found to be heritable. Analyses of multipoint variance component LOD scores, failed to
yield evidence of linkage for stimulant dependence. For the stimulant “craving” phenotype,
linkage analysis revealed a locus that had a LOD score of 3.02 on chromosome 15q25.3-26.1 near
the nicotinic receptor gene cluster. A LOD score of 2.05 was found at this same site for “heavy
stimulant use”. Additional loci with LOD scores above 2.00 were found for stimulant “craving” on
chromosomes 12p13.33-13.32 and 18q22.3. These results corroborate the importance of “craving”
as an important phenotype that is associated with regions on chromosome 12, 15 and 18, that have
been highlighted in prior segregation studies in this and other populations for substance
dependence-related phenotypes.
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Introduction
Stimulants (STIM methamphetamine (MA and cocaine COC are the most commonly used
illicit drugs world-wide second to cannabis use Compton et al., 2004; Maxwell and
Rutkowski, 2008. Recent surveys indicate that MA is the fastest-growing illicit drug of
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choice, particularly in the Western United States and Canada, leading some to describe the
MA problem as an “epidemic” Barr et al., 2006; Tanne, 2006. MA has been demonstrated to
produce psychomotor and cognitive impairments, as well as chronic health problems
[Richards et al., 1999; Paulus et al., 2002; Gonzalez et al., 2004; Ersche and Sahakian, 2007;
Darke et al., 2008; Ersche and Sahakian, 2007; Gonzalez et al., 2004; Paulus et al., 2002;
Richards et al., 1999; Shetty et al., 2010). National surveys suggest that stimulant
dependence also differs among ethnic groups with Native Americans having the highest
rates among all groups evaluated (Iritani et al., 2007; SAMHSA, 2005a,b). Among Native
Americans in drug treatment, the rate of primary amphetamine use has been shown to be
higher than that for other illicit drugs (Evans et al., 2006). From 1997 to 2004, the number of
Indian Health Service outpatient treatment visits attributed to stimulants increased by 30
times (Indian Health Service, 2005). Thus, focusing efforts on understanding the causes of
drug dependence in this minority population is critically needed in order to address health
disparities (Need and Goldstein, 2009).
Twin and family studies have consistently found that stimulant use and use disorders appear
to in part have a genetic basis. Studies that have evaluated the role of genetic and
environmental risk factors on stimulant abuse or stimulant dependence in twin samples have
found heritability estimates that range from 0.39 to 0.79 (see Kendler and Prescott, 1998a,b;
Kendler et al., 2003; Tsuang et al., 1996,1998). Despite these substantial heritability
estimates, identifying genetic loci that confer risk for stimulant misuse disorders has been
difficult given that the genetic architecture underlying these disorders and substance use
disorders in general appears to be polygenic (Barr et al., 2006; Tyrfingsson et al., 2010; Uhl
et al., 2009). Nonetheless, these studies suggest identifying genes that contribute to
involvement with stimulants may be warranted.
Given that disorders of stimulant use likely represent genetically complex traits that are
influenced by a number of genes each of small effect, the genes contributing to the
development of these disorders might be detected if more narrowly defined phenotypes or
subgroups of stimulant dependent individuals can be identified that show an oligogenic
inheritance pattern (i.e., influenced by a small set of genes of moderate effect). For example,
Kranzler et al. (2008) used data reduction methods and an empirical cluster-analytic
approach to identify subgroups of individuals with cocaine dependence based on measures
of cocaine use, cocaine-related effects and treatment history. In their population of small
nuclear families they found a 6 cluster solution, and 4 of the 6 clusters were found to yield
heritability estimates in excess of 0.3. A linkage analysis of the three clusters that contained
>80% of the cocaine dependent subjects revealed a LOD score of 4.66 for membership in
the “Heavy Use, Cocaine predominant” cluster on chromosome 12 and a LOD score of 3.35
for membership in the “Moderate Cocaine and Opioid Abuse” cluster on chromosome 18
(Gelernter et al., 2005). This could indicate that loci of moderate effect are contributing to
the development of these cocaine dependence subtypes.
Of direct relevance to the present study, we have demonstrated that using “craving” or
“strong desire to take a drug” as a phenotype in linkage analyses in populations with drug
dependence can produce genomewide significant LOD scores (Ehlers and Wilhelmsen,
2005; Ehlers et al., 2010a). In one study of an American Indian group, analyses of
multipoint variance component LOD scores for the dichotomous variable “strong desire for
alcohol” revealed evidence for linkage on chromosome 3 with a maximal LOD score of 2.2
and on chromosome 5 with a maximal LOD score of 4.5 (Ehlers and Wilhelmsen, 2005). In
another study of families (The San Francisco Family Study), linkage analyses were
conducted for a phenotype indexing cannabis “craving” (Ehlers et al., 2010a). The symptom
of cannabis “craving” yielded evidence for linkage on chromosome 7 (LOD = 5.7), on
chromosome 3 (LOD=4.4), on chromosome 1 (LOD =3.6), and on chromosome 6 (LOD=
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3.2). Yet no studies to date have conducted linkage analyses specifically on amphetamine
dependence, heavy use, and/or craving phenotypes.
In addition to identifying refined phenotypes, the power of genetic studies of complex
phenotypes, can also be increased when they are conducted in well-defined populations such
as Native American tribes living on reservations (Lander and Schork, 1994). The present
report is part of a larger study exploring risk factors for substance dependence among Native
American Indians (see Ehlers et al., 2001a,b,c,d; 2004a, 2008c; Gilder et al., 2004, 2006,
2007, 2009). The lifetime prevalence of substance dependence in this Indian population is
high and evidence for heritability and linkage to specific chromosome locations and
associations with candidate genes have been demonstrated (see Ehlers and Wilhelmsen,
2005, 2007; Ehlers et al., 2004b, 2006b, 2007a,b,c, 2008a,b, 2009a,b, 2010a,b; Wall et al.,
2003; Wilhelmsen and Ehlers, 2005). The current study’s aims were to: (1) map loci linked
to STIM phenotypes and (2) to determine if there was overlap of the loci identified for
STIM phenotypes and loci previously mapped for alcohol and other substance dependence
in this American Indian community.
Methods
Participants were recruited from eight geographically contiguous reservations, with a total
population of about 3,000 individuals, using a combination of a venue-based method for
sampling hard-to-reach populations (Kalton and Anderson, 1986; Muhib et al., 2001), as
well as a respondent-driven procedure (Heckathorn, 1997) as previously described (Ehlers et
al., 2004a; Gilder et al., 2004). The venues for recruitment included: tribal halls and culture
centers, health clinics, tribal libraries, and stores on the reservations. A 10–25% rate of
refusal was found depending on venue. Refusal rates were higher at tribal libraries and
stores than health clinics and tribal halls/culture centers. Transportation from participants’
homes to The Scripps Research Institute was provided by the study.
To be included in the study, participants had to be a Native American Indian indigenous to
the catchment area, at least 1/16th Native American Heritage (NAH), between the age of 18
and 70 years, and be mobile enough to be transported from his or her home to The Scripps
Research Institute (TSRI). The protocol for the study was approved by the Institutional
Review Board (IRB) of TSRI, and the Indian Health Council, a tribal review group
overseeing health issues for the reservations where recruitment was undertaken.
Potential participants first met individually with research staff to have the study explained
and give written informed consent. During a screening period, participants had blood
pressure and pulse taken, and completed a questionnaire that was used to gather information
on demographics, personal medical history, ethnicity, and drinking history (Schuckit, 1985).
Participants were asked to refrain from alcohol and drug usage for 24 hours prior to the
testing. No individuals with detectable breath alcohol levels were included in the study
dataset (n=3). During the screening period, the study coordinator also noted whether the
participant was agitated, tremulous, or diaphoretic and their data were eliminated from
subsequent analyses. Each participant also completed an interview with the Semi-Structured
Assessment for the Genetics of Alcoholism (SSAGA) and the family history assessment
module (FHAM) (Bucholz et al., 1994), which was used to make substance use disorder and
psychiatric disorder diagnoses according to Diagnostic and Statistical Manual (DSM-III-R)
criteria in the probands and their family members (American Psychiatric Association, 1987).
The SSAGA is a semi-structured, poly-diagnostic psychiatric interview that has undergone
both reliability and validity testing (Bucholz et al., 1994; Hesselbrock et al., 1999). It has
been used in another Native American sample (Hesselbrock et al., 2000, 2003). Personnel
from the Collaborative Study on the Genetics of Alcoholism (COGA) trained all
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interviewers. The SSAGA interview includes retrospective lifetime assessments of alcohol
use, abuse, and dependence. A research psychiatrist/addiction specialist made all best final
diagnoses.
The phenotypes chosen for the present linkage analyses, based on having significant
heritability were: (1) a DSM–III-R stimulant (amphetamine or cocaine) dependence
diagnosis, (2) stimulant “craving” defined as endorsing: “In situations where you couldn’t
use stimulants, did you ever have such a strong desire for it that you couldn’t think of
anything else,” and ( 3) A measure of a period of heavy use of stimulants defined as: “Was
there ever a period of a month or more when a great deal of your time was spent using
stimulants, getting stimulants, or getting over its effects.”
One hundred and eighty-one pedigrees containing 1600 individuals were used in the genetic
analyses. Sixty-six families have only a single individual with phenotype data. All these
individuals were included within some analyses to the extent that they contribute
information about trait means and variance and the impact of covariates. The family sizes
for the remaining families ranged between 4 and 41 subjects (average 12.19 ± 8.19). Eighty-
one families were genetically informative. The data includes 142 parent-child, 260 sibling,
53 half sibling, 11 grandparent-grandchild, 235 avuncular, and 240 cousin relative pairs.
Only sibling, half-sibling, avuncular and cousin pairs were included as being potentially
genetically informative. Several pedigrees contained large numbers of individuals and/or
complex loops that could not be analyzed due to the high computational demands required.
These pedigrees were thus broken using procedures originally described by Lange and
Elston (1975), and treated as independent to allow for their inclusion in the linkage analysis.
DNA was isolated from whole blood using an automated DNA extraction procedure,
genotyping was done as previously described (Wilhelmsen et al., 2003). Genotypes were
determined for a panel of 791 autosomal microsatellite polymorphisms (Weber and May,
1989) using fluorescently labeled PCR primers under conditions recommended by the
manufacturer (HD5 version 2.0; Applied Biosystems, Foster City, CA). The HD5 panel set
has an average marker-to-marker distance of 4.6 cM, and an average heterozygosity of
greater than 77% in a Caucasian population. Allele frequencies observed in the unrelated
founders were used for linkage analysis.
Genotypes were determined for 381 subjects. The PREST software program, which assesses
degree of allele sharing among relative-pairs, was used to identify potential errors in
pedigree structure (McPeek and Sun, 2000). Six individuals were identified as problematic
and removed from further analyses. Pedcheck was then used to detect non-Mendelian
inheritance patterns (O’Connell and Weeks, 1998). When a Mendelian inconsistency was
observed, genotypes for the nuclear family at that polymorphism were removed. This
resulted in the removal of 772 genotypes (0.3%). To further reduce errors, the maximum-
likelihood error-checking algorithm implemented in Merlin (Abecasis et al., 2002) was used
to identify genotypes that had a probability of less than 0.025 of being correct. A total of 508
genotypes (0.2%) were removed in this step. Ultimately 273,598 genotypes (99.5%) were
accepted.
Analyses were conducted to estimate the heritability of the three phenotypes of interest:
DSM-III-R stimulant dependence, stimulant craving, and heavy use using SOLAR (Almasy
and Blangero, 1998) as previously described (see Ehlers et al., 2009). Participant’s age at the
time of evaluation and sex were evaluated as potential covariates and retained if they
accounted for at least 5% of the total variance. The total additive genetic heritability (h2) and
its standard error were estimated, and the probability that h2 was greater than zero was
determined using a Student’s t-test for each scale. All three phenotypes were found to be
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heritable and as such suitable for linkage analyses. There were 684 individuals with full
phenotype data included in these analyses.
For linkage analysis, a variance components approach was used to calculate multipoint LOD
scores at 1 cM intervals across the genome for the three stimulant phenotypes using SOLAR
v4.2.0 (Almasy and Blangero, 1998; S.F.B.R, 2011). Because the Native American Mission
Indian sample contains large extended pedigrees, a variance components approach to
linkage analysis allowing for multiple pedigree types was preferred over sibling pair
approaches (i.e., Kong and Cox statistic (1997)) due to the greater statistical power afforded
by the former (Amos et al., 1997; Duggirala et al., 1997). All traits were analyzed using a
latent threshold model in which a normally distributed trait is assumed along with a
threshold in the distribution above which an individual is designated affected.
Variance components linkage analysis assumes that phenotypes are normally distributed,
and violations of this assumption can result in inflated LOD scores. To protect against this
possibility, simulations were conducted in which a single genetic locus was simulated under
the null hypothesis of no linkage across 100,000 trials to derive pointwise empirical p-
values. These p-values were used to determine the significance of the reported LOD scores
(Blangero et al., 2000) with a p<2.2×10−5 used to identify genome-wide significance as
suggested by Lander and Kruglyak (1995), and p<0.001 to identify suggestive evidence for
linkage. These simulations suggested some negative bias in LOD scores for the stimulant
dependence diagnosis though little bias for the remaining phenotypes as 17, 105, and 72
simulations out of 100,000 for the stimulant dependence, “craving,” and “heavy use”
phenotypes, respectively, yielded LOD scores greater than 2.00 compared to an expected
100 simulations for each phenotype and 0, 4, and 3 out of 100,000 simulations for the
stimulant dependence, “craving,” and “heavy use” phenotypes, respectively, yielded LOD
scores greater than 3.00 compared to an expected 10 simulations for each phenotype.
To better characterize the evidence for linkage across families at the reported peaks,
heterogeneity tests of the family-specific LOD scores were performed using the SOLAR
HLOD (Goring, 2002) test. This test contrasts a null model in which families belong to a
single distribution exhibiting genetic linkage to the tested locus against an alternative model
in which families belong to one of two distributions only one of which shows evidence of
genetic linkage to the tested locus.
Results
Three hundred eighty-one participants out of a larger population of 720 had completed a
SSAGA and had genotyping data that were available for these analyses. Two hundred and
twelve participants met criteria for amphetamine dependence, 17 met criteria for cocaine
dependence and 51 met criteria for both cocaine and amphetamine dependence, for a total
number of participants with either diagnosis (STIM DEP) of 280 which was 40 percent of
the sample. Demographics of this sample are presented in Table 1. There were no significant
differences in the demographics between the participants with phenotyping data and
genotyping available (e.g. the linkage sample, n=381) and the entire sample of participants
in the study with valid SSAGA data (n=720) but no genotyping, at the p<0.01 level.
The phenotype of DSM-III-R STIM DEP (e.g. amphetamine and/or cocaine) was found to
be significantly heritable (h2 =0.21 ± 0.13,p<0.05), as were the symptoms of STIM
“craving” (h2 =0.5 ± 0.20,p<0.003), and STIM heavy use (h2 =0.36 ± 0.36,p<0.006).
Analyses of multipoint variance component LOD scores did not reveal any significant loci
for stimulant dependence. An inspection of the results for the stimulant dependence
phenotype showed that 51.7% of loci yielded a LOD score ≤0, 48.0% of loci yielded a LOD
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score between 0 and 1.00, and 0.3% of loci yielded a LOD >1.00. Analysis of the “craving”
phenotype revealed one locus that had a LOD score greater than 3.0 on chromosome
15q25.3-26.1 at 83 cM (LOD= 3.02) (pointwise empirical p-value=0.00004) and two loci
with LOD scores greater than 2 on chromosomes 12p13.33-13.32 at 5 cM (LOD= 2.11)
(pointwise empirical p-value=0.0009) and 18q22.2 at 113 cM (LOD=2.55) (pointwise
empirical p-value=0.00032). An inspection of the results for the “craving” phenotype
showed that 49.6% of loci yielded a LOD score ≤0, 47.2% of loci yielded a LOD score
between 0 and 1.00, 1.9% of loci yielded a LOD between 1.00 and 2.00, and 1.3% of loci
yielded a LOD score >2.00. One locus was found with a LOD score over 2.0 for the “heavy
use” phenotype on chromosome 1515q25.3-26.1 at 82 cM (LOD=2.04, pointwise empirical
p-value=0.0007). An inspection of the results for the “heavy use” phenotype showed that
52.2% of loci yielded a LOD score ≤0, 46.6% of loci yielded a LOD score between 0 and
1.00, 1.2% of loci yielded a LOD between 1.00 and 2.00, and <0.1% of loci yielded a LOD
score >2.00.
Figure 1 presents the linkage peaks generated by these analyses across the genome. Figure 2
presents data for the three phenotypes for chromosome 15. Table 2 presents the peak LOD
scores, the closest marker location for the loci identified, pointwise empirical p values, and
additionally gives information of other findings in the literature for substance-related
phenotypes observed at or near those locations. Notably, none of the reported peaks
exhibited heterogeneity in LOD scores across pedigrees. The estimated alpha scores, which
can be interpreted as the probability of a given family belonging to a single population
yielding evidence for linkage, were >0.97 for all families at each peak.
Discussion
It has been suggested that the effort to identify genetic factors and the mechanisms whereby
they influence addiction may be aided by the use of phenotypes that may be more closely
related to the biological processes underlying risk for use disorders (Gottesman and Gould,
2003). One phenotype that most substance dependence syndromes have in common is
craving. A general theory of addiction posits that the neurobiological mechanisms
underlying the homeostatic regulation of appetitive drives and instincts becomes
dysregulated during the process of drug exposure (Koob, 2000). Some measures of the
strength of this process include an increase or strong desire to take the drug often called
‘drug craving’ (see Anton, 1999). Human and animal studies have demonstrated that craving
is an important element in the addictive process and that control of craving may improve
efforts at abstinence (see Anton, 1999; Field et al., 2004; Haughey et al., 2008; Heishman
and Singleton, 2006; Robinson and Berridge, 1993; Sinha and O’Malley, 1999; Wise, 1988).
Evaluation of the heritability of stimulant craving (h2 =0.5) and heavy use (h2 =0.36)
demonstrated that these two phenotypes were more heritable than the DSM diagnosis of
stimulant dependence (h2 =0.20). Thus it is notable that three sites in the genome,
chromosomes 12p13.33-13.32, 15q25.3-26.1 and 18q22.3, suggested evidence for linkage to
these latter phenotypes, whereas there was no suggestive evidence for linkage observed for
the stimulant dependence diagnosis.
One location that provided suggestive evidence of linkage was on chromosome
12p13.33-13.32 at 5 cM that had a LOD score of 2.11. A number of previous studies in this
Indian population have found evidence or suggested evidence for linkage for a number of
phenotypes associated with substance dependence including alcohol dependence phenotypes
(Ehlers et al., 2004b), alcohol craving (Ehlers and Wilhelmsen, 2005), tobacco usage (Ehlers
and Wilhelmsen, 2006), cannabis dependence phenotypes (Ehlers et al., 2009), externalizing
diagnoses (Ehlers et al., 2008a), Body Mass Index (Ehlers and Wilhelmsen, 2007), EEG
phenotypes (Ehlers et al., 2010c), and level of response to alcohol (Ehlers et al., 2010d).
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None of these studies found evidence or suggestive evidence for linkage at the site on
chromosome 12 identified for the STIM craving phenotype in the present study suggesting
that it may be unique to this phenotype in this population. However, this site was identified
by Li and colleagues (2008) for a phenotype indexing the number of cigarettes smoked per
day. In that study, a LOD score of 2.49 was found using the variance component method at
6 cM in a EuroAmerican sample, and a LOD score of 4.4 was found at that same site in a
combined sample of EuroAmericans and African Americans.
A second area of the genome that was identified in the present study for the STIM heavy use
and STIM craving phenotypes was on chromosome 15q25.3-26.1 at80 cM (LOD score: 2.05
and 3.02, respectively). This site is near a location that was reported previously as linked to
alcohol withdrawal in this Indian population (Ehlers et al., 2004b), alcohol dependence with
late onset and harm avoidance personality features in the COGA study (Dick et al., 2002),
and a cannabis craving phenotype in the San Francisco Family Alcoholism study (Ehlers et
al., 2009). It contains some promising candidate genes such as NTRK3, which belongs to a
family of genes that encode for neurotrophic tyrosine kinase receptors and is involved in
striatal neuronal development. Notably, NTRK3 expression is increased following cocaine
administration in rats (Freeman et al., 2003; Jung et al., 1996) and is also altered following
prenatal ethanol administration to rat pups (Light et al. 2002; Moore et al., 2004).
The site we identified on human chromosome 15q25.3-26.1 for the STIM phenotypes in the
present study is also approximately 10 Mb telomeric of the human alpha 3 (CHRNA3), alpha
5 (CHRNA5), and beta 4 (CHRNB4) neuronal nicotinic receptor subunit genes on the long
arm of chromosome 15 (15q24) (Raimondi et al., 1992). These receptor genes have been
found to be associated with numerous substance dependence phenotypes including: heavy
smoking and nicotine dependence (Berrettini et al., 2008; Bierut, 2010, a review; Li et al.,
2010; Saccone et al., 2009), opioid dependence severity (Erlich et al., 2010), multiple
dependence phenotypes (Sherva et al., 2010), level of response to alcohol (Joslyn et al.,
2008), and tobacco related cancers (Lips et al., 2010; Truong et al., 2010). Using syntenic
mapping (Ehlers et al., 2010e), this site on human chromosome 15 was found to map to a
region on mouse chromosome 9 where the CHRNA3, CHRNA5, CHRNB4 are located
(Bessis et al., 1990; Eng et al., 1991), as well as genes encoding for cytochrome P45,
subfamily I (CYPlal), mannose phosphate isomerase (MP-1) and the muscle form of
pyruvate kinase (Pk-3) (Cox and Donlon, 1989). Multiple studies performed with mice have
found quantitative trait loci for alcohol preference within this region (Phillips et al., 1994,
1998; Tarantino et al., 1998) as well as associations with nicotine intake (Fowler et al.,
2011). These findings suggest that a large group of homologous sequences may eventually
be found on human chromosome 15 and mouse chromosome 9 that may be important for
substance dependence and that the search for additional candidate genes within this location
may be productive in identifying general mechanisms underlying addiction-related
phenotypes.
One additional site provided suggested evidence for linkage to STIM craving on
chromosome 18q22.3 at 113 cM with a LOD score of 2.55. A few other studies have
identified linkage peaks in this general location on chromosome 18. For instance, Agrawal et
al., (2008) have reported a site on chromosome 18 at 97 cM (LOD=2.14) that was linked to
the frequency of use of cannabis. Additionally, Li et al., (2008) found a broad peak in this
region of chromosome 18 for tobacco use phenotypes in both a EuroAmerican and African
American sample. This area of the genome has not been previously found to be linked to
other substance use phenotypes, including cannabis and tobacco, in this American Indian
population.
Ehlers et al. Page 7













In conclusion, these data represent the first linkage analysis of amphetamine-related
phenotypes in any population. The results suggest that several areas of the genome may
harbor genes that modulate level of addiction to stimulants. Loci highlighted in prior studies
in this population as well as other populations for substance dependence phenotypes were
identified including a site on chromosome 15q25.3-26.1. The results of this study should,
however, be interpreted in the context of several limitations. First, stimulant dependence was
defined by DSM-III-R, and thus, the use of DSM-IV criteria might have produced different
results. For example, the DSM-III-R criteria considered failures to fulfill role obligations
and the use of the substance under hazardous conditions as symptoms of dependence,
whereas the DSM-IV considers these as symptoms of abuse. Such differences in diagnostic
criteria could have influenced the results. Second, the heritability estimate for stimulant
dependence in the present study was lower than has been previously reported, and this may
have contributed to the lack of linkage findings for this phenotype. Third, although dense
coverage was achieved across the genome using microsatellites (average marker-to-marker
distance of 4.6 cM), high throughput genotyping methods can now be used to generate high-
density SNP data for linkage analysis, which might have improved our ability to detect risk
loci. Fourth, the findings of this study may not generalize to other Native Americans or
represent all Native American Indians of the tribes studied, and comparisons of linkage
findings to non-Indian populations may be limited by differences in a host of potential
genetic and environmental variables. Despite these limitations, this report represents an
important step in an ongoing investigation to understand the genetic determinants associated
with the development of substance use disorders in this high risk and understudied ethnic
group.
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Multipoint Linkage Analysis for the heavy stimulant usage (HEAVY USE) stimulant
craving (CRAVING) and stimulant dependence (DEPENDENCE) phenotypes for the entire
genome. Results for each chromosome are aligned end to end with the p terminus on the left.
Log of the Odds (LOD) score is plotted on the Y-axis. Horizontal dashed lines indicated the
cutoffs for suggestive evidence of linkage (LOD > 2.00) and the empirically determined
threshold for genomewide significant evidence of linkage (LOD > 3.33). The numbers
above on the X-axis indicate the chromosome number. Vertical lines indicate the boundaries
between the chromosomes.
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Multipoint Linkage Analysis for the heavy stimulant usage (HEAVY USE) stimulant
craving (CRAVING) and stimulant dependence (DEPENDENCE) phenotypes for
chromosome 15. Log of the Odds (LOD) score (Y-axis) is plotted for the chromosome
location map (in centimorgans (cM), X-axis). Locations of the markers across the peak are
presented. The following numbers indicate the location of previous linkage and association
findings: 1 - Alcohol Withdrawal (Ehlers et al., 2004b), 2 - Anxious Drinking (Dick et al.,
2002), 3 - Cannabis Craving (Ehlers et al., 2010a), 4 - CHRN gene cluster: Lung Cancer
(Truong et al., 2010), Cigarette Smoking (Bierut, 2010; Saccone et al., 2009).
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Table 1
Demographics
Linkage Sample (n = 381) Entire Sample (n = 720)
Gender Male = 149 Female = 232 Male = 299 Female = 421
Married (n) 81 126
Employed (n) 177 286
Income ≥ $20,000 yr. (n) 182 366
Native American Heritage, n ≥ 50% 157 323
Age (yrs) 30.1 ± 0.6 31.1 ± 0.5
Education (yrs) 11.6 ± 0.1 11.6 ± 0.1
Stimulant dependence 157 282
Stimulant craving 98 192
Heavy stimulant use 122 229
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